Find participating medical centers and current study status in each of them

    Find participating medical centers

    A study to evaluate whether Prasinezumab can slow or halt disease progression in people with a recent diagnosis of Parkinson’s disease.

    A Study to Evaluate the Efficacy of RO7046015 in Participants With Early Parkinson’s Disease (PASADENA)

    • Neurodegenerative Disorder
    • Parkinson's Disease (PD)